Chen, Maria
Kim, Boram http://orcid.org/0000-0002-4758-4547
Jarvis, Maria I.
Fleury, Samantha
Deng, Shuyun
Nouraein, Shirin http://orcid.org/0000-0003-3423-1002
Butler, Susan http://orcid.org/0000-0002-7116-7516
Lee, Sangsin http://orcid.org/0000-0002-1306-2206
Chambers, Courtney
Hodges, H. Courtney
Szablowski, Jerzy O. http://orcid.org/0000-0001-7851-5408
Suh, Junghae http://orcid.org/0000-0001-9280-9031
Veiseh, Omid http://orcid.org/0000-0003-1153-8079
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (F30HL146032)
Rice University
U.S. Department of Health & Human Services | NIH | National Institute on Aging (F31AI161906)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA272769, R01CA207497)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Cancer Prevention and Research Institute of Texas (RR160047)
Article History
Received: 21 February 2022
Revised: 11 September 2022
Accepted: 4 October 2022
First Online: 14 November 2022
Competing interests
: JS is an employee of Biogen Inc. as of 2019. OV is a member of the Scientific Advisory Board of Sigilon Therapeutics and holds equity in the Avenge Bio and Pana Bio. The remaining authors declare no competing interests.